Abstract
So far, four viral genes are found to be expressed in latently EBV-infected cells (1, 2, 3, 4, 5, 6). These genes are coding for at least three EBNA associated nuclear proteins and one membrane protein (1, 3, 4, 5, 7, 8). The potential membrane protein is encoded by the BamHI Nhet region (3, 5, 9) and is found to be approximately of 60 000 daltons with varying molecular weights in different EBV genome harbouring lymphoid cell lines. Since two promoters (ED-LI and ED-L1A) map in the BamHI Nhet region two proteins were predicted sharing a common C-terminal region (5). This second protein has been unidentified so far and is supposed to be two thirds in size of the 60 000 Dalton protein. Antisera against both proteins were generated by immunizing rabbits either with a fusion protein containing 155 amino acids of the C-terminus and a 37 000 Daltons part of the bacterial anthranilate synthase (10, 12) or with a C-terminal synthetic peptide of 7 amino acids (H-Val-Gln-Leu-Ser-Tyr-Tyr-Asp-OH). These sera reacted specifically with a protein varying in size between 60 000 and 65 000 Daltons found in all cell lines harbouring EBV (Fig. 1).
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Summers, W.P., Grogan, W.A., Shedd, D., Robert, M., Liu, D-R., and Miller, G. Proc. Natl. Acad. Sci. USA 79, 5688–5692 (1982).
Hennessy, K., and Kieff, E. Proc. Natl. Acad. Sci. USA 80, 5665–5669 (1983).
Hennessy, K., Fennewald, S., Hummel, M., Cole, T., and Kieff, E. Proc. Natl. Sci. USA 81, 7207–7211 (1984).
Hennessy, K., Fennewald, S., and Kieff, E. Proc. Natl. Acad. Sci. USA 82, 5944–5948 (1985).
Hudson, G.S., Farrell, P.J., Barrell, B.G. J. Virol. 53, 528–535 (1985).
Mueller-Lantzsch, N., Lenoir, G.M., Sauter, M., Takaki, K., Béchet, J.-M., Kuklik-Roos, C., Wunderlich, D., and Bornkamm, G.W. EMBO J. 4, 1805–1811 (1985).
Kallin, B., Dillner, J., Einberg, J., Ehlin-Henriksson, B., Rosén, A., Henle, W., Henle, G., and Klein, G. Proc. Natl. Sci. USA 83, 1499–1503 (1986).
Hennessy, K., Wang, F., Woodland-Bushman, E., and Kieff, E. Proc. Natl. Acad. Sci. USA 83, 5693–5697 (1986).
Mann, K.P., Staunton, D., and Thorley-Lawson, D.A. J. Virol. 55, 710–720 (1985)
Koerner, T.J. unpublished results.
Spindler, K.R., Rosser, D.S.E., and Berk, A.J. Journal of Virology 49, 132–141 (1984).
Walter, G., Scheidtmann, K.-H., Carbone, A., Laudano, A.P., and Doolittle, R.F. Proc. Natl. Acad. Sci. USA 77, 5197–5200 (1980).
Boos, H., Berger, R., Kuklik-Roos, C., and Mueller-Lantzsch, N., submitted (1986).
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1987 The Humana Press Inc.
About this chapter
Cite this chapter
Boos, H., Berger, R., Kuklik-Roos, C., Mueller-Lantzsch, N. (1987). Epstein-Barr Virus Protein (LMP) Expression is Enhanced by Serum, TPA or Butyrate. In: Levine, P.H., Ablashi, D.V., Nonoyama, M., Pearson, G.R., Glaser, R. (eds) Epstein-Barr Virus and Human Disease. Experimental Biology and Medicine, vol 15. Humana Press. https://doi.org/10.1007/978-1-4612-4590-2_49
Download citation
DOI: https://doi.org/10.1007/978-1-4612-4590-2_49
Publisher Name: Humana Press
Print ISBN: 978-1-4612-8940-1
Online ISBN: 978-1-4612-4590-2
eBook Packages: Springer Book Archive